insights_auto
Why is NWBO up 3.43%?
Dive Deeperchevron_right
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.17
arrow_upward
+3.43%(+0.0055) 1D
Oct 13, 12:23:44 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
$0.16
High
$0.17
Low
$0.16
Mkt. cap
289.27M
Avg. vol.
4.28M
Volume
3.84M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.62
Shares outstanding
1.71B
No. of employees
105
Open
$0.16
High
$0.17
Low
$0.16
Mkt. cap
289.27M
Avg. vol.
4.28M
Volume
3.84M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.62
Shares outstanding
1.71B
No. of employees
105
News stories
From web sources and news partners
FXStreet
·
1 hour ago
Few Stocks are holding the S&P up: Is that a warning? [Video]
Traders Union
·
1 hour ago
S&P 500 rises 118% in four years, Phil Rosen notes
Kalkine Media
·
55 minutes ago
Why Is Dynatrace (NYSE:DT) Reaching New Highs in the S&P 500?
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc